CorMedix (CRMD) Share-based Compensation (2010 - 2025)

CorMedix has disclosed Share-based Compensation across 14 years of filings, most recently posting $3.6 million for Q4 2025.

• Share-based Compensation for Q4 2025 came in at $3.6 million, up 200.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.8 million (up 125.68% YoY), and the FY2025 annual result was $13.8 million, up 125.68% from the prior year.
• Share-based Compensation came in at $3.6 million for Q4 2025 at CorMedix, down from $4.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q3 2025 to a low of $50000.0 in Q2 2022.
• The 5-year median for Share-based Compensation is $1.2 million (2023), against an average of $1.7 million.
• Across the five-year window, Share-based Compensation slumped 95.05% in 2022 and jumped 1878.0% in 2023, its largest moves.
• CorMedix's Share-based Compensation stood at $1.3 million in 2021, then sank by 30.26% to $874051.0 in 2022, then surged by 39.27% to $1.2 million in 2023, then slipped by 1.95% to $1.2 million in 2024, then surged by 200.71% to $3.6 million in 2025.
• The last three Share-based Compensation figures came in at $3.6 million (Q4 2025), $4.1 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.